Uber, Cabcharge, GoCatch and the race to win ridesharing

Imagine trying to take on a company which has billions in the bank, no pressure from the public markets to perform and an absolutely fearless attitude towards regulators and governments. This doesn’t require a huge leap of the imagination because that company exists.

Have you got my card? Six networking fails to avoid at work

Meeting and greeting, boozing and schmoozing, connecting or professional networking is intrinsic to the business of building a circle of contacts, or climbing the corporate ladder. Doing it well can pay handsome dividends – research suggests that up to 80 per cent of jobs are not advertised formally but go to individuals whose reputation precedes them, or who have an ‘in’ with someone who counts.

Cabcharge sweetens services to keep up with Uber after 45 per cent profit drop

Cabcharge is overhauling the services offered by its taxis to stay competitive with ridesharing groups like Uber and GoCatch, chief executive Andrew Skelton said after the company’s annual net profit slid 45 per cent to $25.6 million. Customer expectations of how technology works and services are delivered had changed, Mr Skelton said.

Brisbane startup Travello secures $1.26 million to take things to the next level – StartupSmart

Brisbane startup Travello has secured $1.26 million in funding as it looks to take its social network for travellers to the next level. Travello, previously called Outbound, offers a platform for travellers to meet and connect with others when abroad and is now used in more than 200 countries.

Masterchef the most-watched non-news show, Seven wins with news double – Mumbrella

News dominated a quiet Thursday evening with no non-news show breaking the 1m viewer mark with Ten’s Masterchef pulling in 912,000 metro viewers at 7:30pm to be the most-watched non-news program of the evening. The cooking show easily out-rated Nine’s RBT, which was watched by 610,000.

DoseMe to invest in EMR integration following capital raising

Medications dose individualisation software developer DoseMe is set to invest in commercialising the product in Australia and integrating it with electronic medical records as it prepares for entry into the US and European markets, following the successful closure of a $2.6 million Series A financing round.